SUTIMLIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 13:09:29 GMT 2023` Edited by `admin` on `Sat Dec 16 13:09:29 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG4
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	GNWE7KJ995
Record Status	`Validated (UNII)`
Record Version

Download

Related Record	Type

Name

Type

Language

SUTIMLIMAB

Official Name

English

SUTIMLIMAB [USAN]

Common Name

English

TNT-009

Code

English

IMMUNOGLOBULIN G4, ANTI-(HUMAN COMPLEMENT C1S) (HUMANIZED MOUSE MONOCLONAL TNT009 .GAMMA.4-CHAIN), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL TNT009 .KAPPA.-CHAIN, DIMER

Common Name

English

BIVV009

Code

English

TNT009

Code

English

BIVV-009

Common Name

English

sutimlimab [INN]

Common Name

English

Sutimlimab [WHO-DD]

Common Name

English

SUTIMLIMAB [JAN]

Common Name

English

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS COMPLEMENT C1S SUBCOMPONENT (C1 ESTERASEEC=3.4.21.42)) HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY.GAMMA.4 HEAVY CHAIN (1-445) (HUMANIZED VH (HOMO SAPIENS IGHV3-23*03 (90%) (IGHD)-IGHJ4*01) (8.8.11) (1-118)-HOMO

Systematic Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

506115

Created by admin on Sat Dec 16 13:09:29 GMT 2023 , Edited by admin on Sat Dec 16 13:09:29 GMT 2023

FDA ORPHAN DRUG

614317

Created by admin on Sat Dec 16 13:09:29 GMT 2023 , Edited by admin on Sat Dec 16 13:09:29 GMT 2023

FDA ORPHAN DRUG

597117

Created by admin on Sat Dec 16 13:09:29 GMT 2023 , Edited by admin on Sat Dec 16 13:09:29 GMT 2023

NCI_THESAURUS

C20401

Created by admin on Sat Dec 16 13:09:29 GMT 2023 , Edited by admin on Sat Dec 16 13:09:29 GMT 2023

Code System Code Type Description

FDA UNII

GNWE7KJ995

Created by admin on Sat Dec 16 13:09:29 GMT 2023 , Edited by admin on Sat Dec 16 13:09:29 GMT 2023

PRIMARY

USAN

GH-88

Created by admin on Sat Dec 16 13:09:29 GMT 2023 , Edited by admin on Sat Dec 16 13:09:29 GMT 2023

PRIMARY

NCI_THESAURUS

C153093

Created by admin on Sat Dec 16 13:09:29 GMT 2023 , Edited by admin on Sat Dec 16 13:09:29 GMT 2023

PRIMARY

WIKIPEDIA

Sutimlimab

Created by admin on Sat Dec 16 13:09:29 GMT 2023 , Edited by admin on Sat Dec 16 13:09:29 GMT 2023

PRIMARY

DAILYMED

GNWE7KJ995

Created by admin on Sat Dec 16 13:09:29 GMT 2023 , Edited by admin on Sat Dec 16 13:09:29 GMT 2023

PRIMARY

INN

10737

Created by admin on Sat Dec 16 13:09:29 GMT 2023 , Edited by admin on Sat Dec 16 13:09:29 GMT 2023

PRIMARY

CAS

2049079-64-1

Created by admin on Sat Dec 16 13:09:29 GMT 2023 , Edited by admin on Sat Dec 16 13:09:29 GMT 2023

PRIMARY

RXCUI

2591404

Created by admin on Sat Dec 16 13:09:29 GMT 2023 , Edited by admin on Sat Dec 16 13:09:29 GMT 2023

PRIMARY

CAS

1792211-85-8

Created by admin on Sat Dec 16 13:09:29 GMT 2023 , Edited by admin on Sat Dec 16 13:09:29 GMT 2023

NO STRUCTURE GIVEN

DRUG BANK

DB14996

Created by admin on Sat Dec 16 13:09:29 GMT 2023 , Edited by admin on Sat Dec 16 13:09:29 GMT 2023

PRIMARY

From	To
1_22	1_96
1_132	3_216
1_145	1_201
1_224	2_224
1_227	2_227
1_259	1_319
1_365	1_423
2_22	2_96
2_132	4_216
2_145	2_201
2_259	2_319
2_365	2_423
3_23	3_89
3_136	3_196
4_23	4_89
4_136	4_196

Glycosylation Link Type	Site
N	1_295
N	2_295

Related Record Type Details

SUTIMLIMAB-JOME

SUB_CONCEPT->SUBSTANCE

Amount:


					XLK873Z96Y

COMPLEMENT C1S SUBCOMPONENT

TARGET -> INHIBITOR

Related Record Type Details


					GNWE7KJ995

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL